| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.21 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |